Statistics

Total Visits

	Views
Development of a New Antileishmanial Aziridine-2,3-Dicarboxylate-Based Inhibitor with High Selectivity for Parasite Cysteine Proteases.	20

	October 2025	November 2025	December 2025	January 2026	February 2026	March 2026	April 2026
Development of a New Antileishmanial Aziridine-2,3-Dicarboxylate-Based Inhibitor with High Selectivity for Parasite Cysteine Proteases.	0	0	0	0	0	3	17

	Views
Schad et al 2015.pdf	19

	Views

	Views